Jump to main content.


Commercial Hexane and Methylcyclopentane (MCP) Test Results


Alphabetical Listing

A B C D E
F G H I bulletJ
bulletK bulletL M N O
P Q R S T
U V bulletW X bulletY
bulletZ
All
Chemical Testing Homepage
CAS Nos. This PRM proposes testing for both a chemical substance methylcyclopentane (MCP) and a commercial product (commercial hexane). Commercial hexane is a mixture of several C6 hydrocarbons, including n-hexane, MCP, 2-methylpentane (2-MP), 3-methylpentane (3-MP), 2,2-dimethylbutane (2,2-DMB), 2,3-dimethylbutane (2,3-DMB), cyclohexane, and benzene. The CAS number for methyl cyclopentane is 96-37-7. No CAS number is available for commercial hexane.

ITC Designation - Sixteenth Report
50 FR 20930; May 21, 1985

Proposed Test Rule (PRM)
51 FR 17854; May 15, 1986

Final Test Rule (FRM)

Decision Not to Test/Methylcyclopentane (DNT)
53 FR 3382; February 5, 1988
American Petroleum Institute

Final Test Rule/Pharmacokinetics (FRMA)
55 FR 627; January 8, 1990

Modifications
53 FR 19315; May 27, 1988/Definition of Test Substance (Proposed)
53 FR 38952; October 4, 1988/Definition of Test Substance (Final)
53 FR 45289; November 9, 1988/Pharmacokinetics Test Standard (Proposed)
55 FR 12639; April 5, 1990/Test Standard
57 FR 24958; June 12, 1992/Technical Amendment

Project Manager: B. Fountos, C. Roman

Section Chief: F. Benenati

Status: Closed. All required tests have been completed. Test results have been forwarded to the Risk Assessment Division for review and disposition.

Announced Receipt of Test Data

The American Petroleum Institute (API) submitted a Salmonella/mammalian-microsome mutagenicity assay of the vapor-phase commercial hexane (54 FR 21117; August 4, 1989).

Developmental toxicity study of commercial hexane vapor (rats and mice) (54 FR 52449; December 21, 1989).

Subchronic inhalation toxicity study of commercial hexane (rats and mice) with special pathology report; Inhalation study of the potential effects of commercial hexane on behavior and neuromorphology; an acute operant behavior study ofinhaled commercial hexane (rat); Chromosomal aberration in CHO cells exposed to commercial hexane (55 FR 9504; March 14, 1990).

The API submitted a subchronic in vivo inhalation cytogenetics assay (rat) (55 FR 27303; July 2, 1990).

API submitted a 2-generation inhalation study in rats (56 FR 22715; May 16, 1991).

An API submission describes the disposition and pharmacokinetics of commercial hexane following iv bolus injection, dermal absorption or nose-only inhalation (57 FR 45056; September 30, 1992).

“An inhalation oncogenicity study of commercial hexane in rats and mice: Part I -Rats” was submitted by the American Petroleum Institute on behalf of the test sponsors and received by EPA on May 12, 1993 (58 FR 32122; June 8,1993).

“An inhalation oncogenicity study of commercial hexane in rats and mice: Part II -Mice” was submitted by the American Petroleum Institute on behalf of the test sponsors and received by EPA on June 22, 1993 (58 FR 40427; July 28,1993).

Results of Testing Table



Local Navigation


Jump to main content.